--- title: "美皓医疗集团有限公司 (01947.HK)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/01947.HK.md" symbol: "01947.HK" name: "美皓医疗集团有限公司" industry: "医疗服务" --- # 美皓医疗集团有限公司 (01947.HK) | Item | Detail | |------|--------| | Industry | 医疗服务 | | Location | 港股市场 | | Website | [www.meihaomedical.com](https://www.meihaomedical.com) | ## Company Profile 美皓医疗集团有限公司是一家主要提供私人牙科服务的投资控股公司。该公司主要经营四种业务。口腔综合治疗科业务从事口腔面部疾病的检查、诊断、预防及治疗。牙齿正畸科业务专注于诊断、预防、阻断及通过不同类型的牙套矫正错牙或畸形以及形成中或已成熟的口面结构的骨骼异常。口腔修复科业务专注于恢复缺损牙齿结构的功能、完整性及形态。种植牙科业务专注于通过手术将种植牙种植体放置在患者的颚骨中作为结构基础,以义齿取代受损或缺失的牙齿。 ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-17T04:30:10.000Z **Overall: C (0.53)** **Industry**: Health Care Services | Metric | Value | |--------|-------| | Industry Ranking | 14 / 29 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 16.94% | | | Net Profit YoY | -3.21% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 1.83 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 219.02M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 91.56M | | **Multi Score**: C #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -20.98% | E | | Profit Margin | -32.39% | E | | Gross Margin | 36.77% | C | #### Growth Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 16.94% | B | | Net Profit YoY | -3.21% | C | | Total Assets YoY | -16.22% | E | | Net Assets YoY | -26.31% | E | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -308.70% | D | | OCF YoY | 16.94% | B | #### Operating Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.41 | C | #### Debt Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 40.16% | C | ```chart-data:radar { "title": "Longbridge Financial Score - 美皓医疗集团有限公司", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-20.98%", "rating": "E" }, { "name": "Profit Margin", "value": "-32.39%", "rating": "E" }, { "name": "Gross Margin", "value": "36.77%", "rating": "C" } ] }, { "name": "Growth", "grade": "C", "indicators": [ { "name": "Revenue YoY", "value": "16.94%", "rating": "B" }, { "name": "Net Profit YoY", "value": "-3.21%", "rating": "C" }, { "name": "Total Assets YoY", "value": "-16.22%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-26.31%", "rating": "E" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "-308.70%", "rating": "D" }, { "name": "OCF YoY", "value": "16.94%", "rating": "B" } ] }, { "name": "Operating", "grade": "C", "indicators": [ { "name": "Turnover", "value": "0.41", "rating": "C" } ] }, { "name": "Security", "grade": "C", "indicators": [ { "name": "Gearing Ratio", "value": "40.16%", "rating": "C" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 固生堂 (HK.2273) | B | B | B | B | B | B | | 02 | 盈健医疗 (HK.1419) | C | C | B | B | B | B | | 03 | 环球医疗 (HK.2666) | B | C | D | D | B | C | | 04 | 健康之路 (HK.2587) | B | C | A | D | E | C | | 05 | 卓正医疗 (HK.2677) | D | A | B | E | B | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -7.30 | 21/30 | - | - | - | | PB | 1.83 | 18/30 | 1.83 | 1.70 | 1.35 | | PS (TTM) | 2.37 | 20/30 | 2.57 | 2.33 | 2.20 | | Dividend Yield | 0.00% | - | 3.23% | 2.94% | 2.82% | ## References - [Company Overview](https://longbridge.com/en/quote/01947.HK/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/01947.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/01947.HK/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.